The global Chronic Hepatitis B Virus Testing market garnered a market value of USD 919 Million in 2023 and is expected to accumulate a market value of USD 1790 Million by registering a CAGR of 6.9% in the forecast period 2023 to 2033. Growth of the Chronic Hepatitis B Virus Testing market can be attributed to technological advancement in diagnostic tools along with increased awareness regarding testing methodologies.
The market for Chronic Hepatitis B Virus Testing registered a CAGR of 5.1% in the historical period 2018 to 2022
Chronic Hepatitis B Virus (HBV) testing refers to a series of laboratory tests that detect the presence of the virus in the blood over an extended period. Chronic hepatitis B is a condition in which the HBV infection lasts for more than six months.
Chronic HBV testing typically involves blood tests that detect various markers of the virus, including the hepatitis B surface antigen (HBsAg), the hepatitis B core antibody (anti-HBc), the hepatitis B e antigen (HBeAg), and the hepatitis B surface antibody (anti-HBs). These markers help to determine the stage and severity of the infection, as well as the risk of transmission to others.
Testing for chronic HBV is crucial because it can lead to severe liver damage, including cirrhosis and liver cancer, if left untreated. Early detection of the infection can help to manage the condition and prevent complications. Treatment options for chronic HBV include antiviral medications and regular monitoring of liver function.
| Report Attribute | Details |
|---|---|
| Expected Market Value (2023) | USD 919 Million |
| Anticipated Forecast Value (2033) | USD 1790 Million |
| Projected Growth Rate (2023 to 2033) | 6.9% CAGR |
According to market research and competitive intelligence provider Future Market Insights- the market for Chronic Hepatitis B Virus Testing reflected a value of 5.1% during the historical period, 2018 to 2022.
The growth of the market is driven by several factors such as the increasing prevalence of chronic HBV infections, the rising demand for early diagnosis, and the development of advanced diagnostic technologies. The North America region accounted for the largest share of the market, followed by Europe.
This was attributed to the high prevalence of chronic HBV infections in countries such as USA and Canada, as well as the availability of advanced diagnostic technologies in developed countries.Thus, the market for Chronic Hepatitis B Virus Testing is expected to register a CAGR of 6.9% in the forecast period 2023 to 2033.
Rising demand for early diagnosis spurring the demand for testing services
HBV is one of the most common viral infections worldwide, with an estimated 292 million people living with chronic HBV infections. This high prevalence drives the demand for HBV testing and monitoring, as early diagnosis and treatment are crucial to prevent disease progression. Early diagnosis of chronic HBV infection is critical to prevent complications such as cirrhosis and liver cancer. As a result, there is a growing demand for diagnostic tests that can detect the virus in its early stages.
Advances in diagnostic technologies, such as nucleic acid testing (NAT) and point-of-care testing (POCT), have made it easier and faster to detect HBV infections accurately. These technologies have improved the accuracy and sensitivity of HBV testing, leading to more effective diagnosis and treatment.
Governments around the world have launched various initiatives to control the spread of HBV and improve access to testing and treatment. For example, the World Health Organization (WHO) has set a target to eliminate HBV as a public health threat by 2030, which is likely to drive demand for testing.
Public awareness campaigns and education programs have helped to increase awareness about the importance of HBV testing and treatment. As a result, more people are seeking testing for HBV, driving demand for diagnostic tests.
Development of advanced diagnostic technologies bolstering demand for Chronic Hepatitis B Virus Testing Market
Hepatitis B surface antigen (HBsAg) test: This test detects the presence of the HBV surface antigen in the blood, which indicates an active HBV infection.
Hepatitis B core antibody (anti-HBc) test: This test detects the presence of antibodies to the HBV core antigen, which indicates a previous or ongoing HBV infection.
Hepatitis B surface antibody (anti-HBs) test: This test detects the presence of antibodies to the HBV surface antigen, which indicates immunity to HBV or successful vaccination against HBV.
Hepatitis B e antigen (HBeAg) test: This test detects the presence of the HBeAg protein, which indicates active viral replication and a higher risk of transmitting the virus to others.
Hepatitis B viral load test: This test measures the amount of HBV DNA in the blood, which can help to monitor the progression of the infection and the effectiveness of treatment.
Liver function tests: These tests measure levels of enzymes and proteins in the blood that are produced by the liver, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST), which can indicate liver damage or disease.
Limited access to testing in developing countries along with high cost of testing affecting market growth
Access to testing for chronic HBV infections can be limited in developing countries due to factors such as a lack of healthcare infrastructure, limited resources, and poor public awareness of the disease. The cost of diagnostic tests for chronic HBV infections can be high, which may limit access for some patients, particularly those without adequate insurance coverage.
The accuracy of diagnostic tests for chronic HBV infections can vary, leading to false-positive or false-negative results. This can lead to delays in diagnosis and treatment or unnecessary treatment and monitoring. Stigma and discrimination surrounding HBV infection can deter some patients from seeking testing and treatment, particularly in certain cultures where there may be a strong association between the disease and social stigma.
Many people are unaware of the risk factors for HBV infection and the importance of testing and treatment. This can lead to a lack of demand for testing and lower rates of diagnosis and treatment. While there are treatments available for chronic HBV infection, they may not be effective for all patients and can have significant side effects. This can make it difficult to manage the disease and may limit the effectiveness of testing in some cases.
Presence of established healthcare infrastructure propelling market growth in North America
The market growth in North America is driven by factors such as the high prevalence of chronic HBV infection in the region, increasing awareness about the importance of early diagnosis and treatment, and the availability of advanced diagnostic technologies. Additionally, the presence of established healthcare infrastructure and favorable government initiatives to control the spread of HBV have contributed to the growth of the market.
Factors such as a large patient population and a strong focus on research and development in the healthcare industry are contributing to the growth of the market. However, the market in Canada is also expected to grow at a significant rate, driven by factors such as increasing public awareness and government initiatives to improve access to testing and treatment.
Overall, the North America Chronic Hepatitis B Virus Testing Market is expected to continue to grow in the coming years, driven by factors such as increasing demand for accurate and reliable diagnostic tests and a growing focus on disease prevention and management in the healthcare industry. Thus, North America is expected to possess 44% market share for Chronic Hepatitis B Virus Testing Market in 2023.
Increasing number of people undergoing HBV testing boosting market growth
Factors such as increasing demand for accurate and reliable diagnostic tests and a growing focus on disease prevention and management in the healthcare industry is driving the growth of the market in Europe. The market is also expected to grow at a significant rate, driven by factors such as increasing public awareness and government initiatives to improve access to testing and treatment. In addition, the European governments are focusing on developing programs for early detection and treatment of hepatitis B virus infection. This has led to an increase in the number of people undergoing HBV testing, which is driving the growth of the market.
There have been significant advancements in the development of testing technologies for HBV, such as point-of-care tests and nucleic acid testing. This has made testing more accessible and affordable, which has contributed to the growth of the market. Overall, the Europe Chronic Hepatitis B Virus Testing Market is expected to continue to grow in the coming years. Thus, Europe is expected to possess 39% market share for Chronic Hepatitis B Virus Testing Market in 2023.
Reliable results maximizing use of EIA kits for testing Chronic Hepatitis B Virus Testing
Enzyme Immunoassay (EIA) kits are widely used for Chronic Hepatitis B Virus (HBV) Testing, and they are considered to be a reliable and accurate option for detecting HBV infection. EIA kits are laboratory-based tests that detect specific antibodies or antigens to HBV in a patient's blood sample.
EIA kits are highly sensitive and specific, meaning that they can accurately detect the presence of HBV in a patient's blood with a low rate of false-positive or false-negative results. They are also easy to use and can provide results within a short period of time, typically within a few hours. Thus, EIA kits are expected to hold 53% market share for Chronic Hepatitis B Virus Testing Market in 2023.
Key players in the Chronic Hepatitis B Virus Testing market are Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Janssen Sciences Ireland, Assembly Biosciences, Janssen and Arrowhead Pharmaceuticals, Roche, Vir Biotechnology, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Abbott Laboratories, Meridian Bioscience
| Report Attribute | Details |
|---|---|
| Market Value in 2023 | USD 919 Million |
| Market Value in 2033 | USD 1790 Million |
| Growth Rate | CAGR of 6.9% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD Million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, End User, RegionProduct Type, End User, Region |
| Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Rest of Latin America, Germany, United Kingdom, France, Spain, Italy, Rest of Europe, India, Malaysia, Singapore, Thailand, Rest of South Asia, China, Japan, South Korea, Austria, New Zealand, GCC countries, South Africa, Israel, Rest of MEA |
| Key Companies Profiled | Gilead Sciences; GlaxoSmithKline; Ionis Pharma; Janssen Sciences Ireland; Assembly Biosciences; Janssen and Arrowhead Pharmaceuticals; Roche; Vir Biotechnology; Bio-Rad Laboratories, Inc.; DiaSorin S.p.A.; Abbott Laboratories; Meridian Bioscience |
| Customization | Available Upon Request |
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 8: Latin America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 10: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 11: Europe Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 12: Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 13: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: South Asia Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 15: South Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 16: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 17: East Asia Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 18: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 19: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 20: Oceania Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 21: Oceania Market Value (US$ Million) Forecast by End User, 2018 to 2033
Table 22: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 23: MEA Market Value (US$ Million) Forecast by Product Type, 2018 to 2033
Table 24: MEA Market Value (US$ Million) Forecast by End User, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by End User, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 7: Global Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 8: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 9: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 10: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 13: Global Market Attractiveness by Product Type, 2023 to 2033
Figure 14: Global Market Attractiveness by End User, 2023 to 2033
Figure 15: Global Market Attractiveness by Region, 2023 to 2033
Figure 16: North America Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 17: North America Market Value (US$ Million) by End User, 2023 to 2033
Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 22: North America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 23: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 24: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 28: North America Market Attractiveness by Product Type, 2023 to 2033
Figure 29: North America Market Attractiveness by End User, 2023 to 2033
Figure 30: North America Market Attractiveness by Country, 2023 to 2033
Figure 31: Latin America Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 32: Latin America Market Value (US$ Million) by End User, 2023 to 2033
Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 37: Latin America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 43: Latin America Market Attractiveness by Product Type, 2023 to 2033
Figure 44: Latin America Market Attractiveness by End User, 2023 to 2033
Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 46: Europe Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 47: Europe Market Value (US$ Million) by End User, 2023 to 2033
Figure 48: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 52: Europe Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 53: Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 55: Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 56: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 57: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 58: Europe Market Attractiveness by Product Type, 2023 to 2033
Figure 59: Europe Market Attractiveness by End User, 2023 to 2033
Figure 60: Europe Market Attractiveness by Country, 2023 to 2033
Figure 61: South Asia Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 62: South Asia Market Value (US$ Million) by End User, 2023 to 2033
Figure 63: South Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 64: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 65: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 66: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 67: South Asia Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 68: South Asia Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 69: South Asia Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 70: South Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 71: South Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 72: South Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 73: South Asia Market Attractiveness by Product Type, 2023 to 2033
Figure 74: South Asia Market Attractiveness by End User, 2023 to 2033
Figure 75: South Asia Market Attractiveness by Country, 2023 to 2033
Figure 76: East Asia Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 77: East Asia Market Value (US$ Million) by End User, 2023 to 2033
Figure 78: East Asia Market Value (US$ Million) by Country, 2023 to 2033
Figure 79: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 80: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 81: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 82: East Asia Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 83: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 84: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 85: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 86: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 87: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 88: East Asia Market Attractiveness by Product Type, 2023 to 2033
Figure 89: East Asia Market Attractiveness by End User, 2023 to 2033
Figure 90: East Asia Market Attractiveness by Country, 2023 to 2033
Figure 91: Oceania Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 92: Oceania Market Value (US$ Million) by End User, 2023 to 2033
Figure 93: Oceania Market Value (US$ Million) by Country, 2023 to 2033
Figure 94: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 95: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 96: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 97: Oceania Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 98: Oceania Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 99: Oceania Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 100: Oceania Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 101: Oceania Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 102: Oceania Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 103: Oceania Market Attractiveness by Product Type, 2023 to 2033
Figure 104: Oceania Market Attractiveness by End User, 2023 to 2033
Figure 105: Oceania Market Attractiveness by Country, 2023 to 2033
Figure 106: MEA Market Value (US$ Million) by Product Type, 2023 to 2033
Figure 107: MEA Market Value (US$ Million) by End User, 2023 to 2033
Figure 108: MEA Market Value (US$ Million) by Country, 2023 to 2033
Figure 109: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 110: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 111: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 112: MEA Market Value (US$ Million) Analysis by Product Type, 2018 to 2033
Figure 113: MEA Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033
Figure 114: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033
Figure 115: MEA Market Value (US$ Million) Analysis by End User, 2018 to 2033
Figure 116: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 117: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 118: MEA Market Attractiveness by Product Type, 2023 to 2033
Figure 119: MEA Market Attractiveness by End User, 2023 to 2033
Figure 120: MEA Market Attractiveness by Country, 2023 to 2033
The market is estimated to reach USD 1,790 million by 2033.
The presence of established healthcare infrastructure propels market growth.
Limited access to testing in developing countries restrains market growth.
Rising demand for early diagnosis spurs the demand for testing services.
North America holds a substantial share of the market.
Explore Similar Insights
Chronic Hepatitis B Virus Testing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
